Evidence map›Paper›PMID 35353055›Full record

Trial reportJMIR mHealth and uHealth2022

Web-Based TangPlan and WeChat Combination to Support Self-management for Patients With Type 2 Diabetes: Randomized Controlled Trial.

Shu-Fang Xia, Gusonghan Maitiniyazi, Yue Chen, Xiao-Ya Wu, Yu Zhang, Xiao-Yan Zhang, Zi-Yuan Li, Yuan Liu, Yu-Yu Qiu, Jun Wang

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in JMIR mHealth and uHealth, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 8 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 8 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Smartphone application-based interventions for cardiometabolic risk factor management: A systematic review and meta-analysis.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Smartphone application-based intervention to lower blood pressure: a systematic review and meta-analysis.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Smartphone-Based Cancer and Obesity Prevention Education Program for Chinese Women (SCOPE): A Pilot RCT.International journal of environmental research and public health · 2023
    Trial
  13. Trial
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Digital Health Technology in Diabetes Management in the Asia-Pacific Region: A Narrative Review of the Current Scenario and Future Outlook.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Shu-Fang Xia *Wuxi School of Medicine, Jiangnan University, Wuxi, China.ORCID 0000-0002-8977-4760
Gusonghan Maitiniyazi *Wuxi School of Medicine, Jiangnan University, Wuxi, China.ORCID 0000-0002-5436-8156
Yue Chen *Wuxi School of Medicine, Jiangnan University, Wuxi, China.ORCID 0000-0003-1298-7415
Xiao-Ya Wu *Department of Rehabilitation, Wuxi 9th Affiliated Hospital of Soochow University, Wuxi, China.ORCID 0000-0002-3703-5368
Yu ZhangDepartment of Endocrinology, Affiliated Hospital of Jiangnan University, Wuxi, China.ORCID 0000-0002-3944-3672
Xiao-Yan ZhangDepartment of Hepatobiliary Surgery, Affiliated Hospital of Jiangnan University, Wuxi, China.ORCID 0000-0002-7805-4768
Zi-Yuan LiWuxi School of Medicine, Jiangnan University, Wuxi, China.ORCID 0000-0002-8972-5352
Yuan LiuWuxi School of Medicine, Jiangnan University, Wuxi, China.ORCID 0000-0003-2866-5138
Yu-Yu QiuWuxi School of Medicine, Jiangnan University, Wuxi, China.ORCID 0000-0002-9065-888X
Jun WangDepartment of Rehabilitation, Wuxi 9th Affiliated Hospital of Soochow University, Wuxi, China.ORCID 0000-0002-4298-148X
Jiangnan University · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChina has the largest number of patients with type 2 diabetes mellitus (T2DM) in the world. However, owing to insufficient knowledge of self-management in patients with diabetes, blood glucose (BG) control is poor. Most diabetes-related self-management applications fail to bring significant benefits to patients with T2DM because of the low use rate and difficult operation.

objectiveThis study aims to examine the effectiveness of the combination of the self-designed web-based T2DM management software TangPlan and WeChat on fasting BG (FBG), glycated hemoglobin (HbA

methodsParticipants were recruited and randomized into the TangPlan and WeChat or control groups. Participants in the control group received usual care, whereas the TangPlan and WeChat participants received self-management guidance with the help of TangPlan and WeChat from health care professionals, including BG self-monitoring; healthy eating; active physical exercise; increasing medication compliance; and health education during follow-ups, lectures, or web-based communication. They were also asked to record and send self-management data to the health care professionals via WeChat to obtain timely and effective guidance on diabetes self-management.

resultsIn this study, 76.9% (120/156) of participants completed the 6-month follow-up visit. After the intervention, FBG (mean 6.51, SD 1.66 mmol/L; P=.048), HbA

conclusionsCompared with usual care for patients with T2DM, the combination of TangPlan and WeChat was effective in improving glycemic control (decrease in HbA

trial registrationChinese Clinical Trial Registry ChiCTR2000028843; https://tinyurl.com/559kuve6.

Indexed as

Diabetes Mellitus, Type 2Self-ManagementExerciseGlycated HemoglobinHumansInternetGlycated Hemoglobinglucose controlself-managementTangPlantype 2 diabetesWeChat

Identifiers

PMID35353055
PMCPMC9008529
OpenAlexW4220967931

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.